BIOpharmaceuticals
CURING CANCER BY ACTIVATING EACH PATIENT'S IMMUNE MEMORY
SCIENCE
Athena
Our targeted approach is based on a short list of both
a) highly immunogenic and
b) highly conserved epitopes for SARS
Our delivery utilizes a proven, standardized and safe approach based on a recombinant influenza vaccine
This technology may also result in combined immunization against both coronavirus and flu infections
Our targeted approach is based on a short list of both
a) our drugs specifically activate immune cells at the site of the tumor, thus resulting in more efficient cancer killing and decreased side effects.
b) they also stay at the damaged tissue after the cancer is removed and prevent recurrence and metastasis (resulting in the cure).